5 showed a decreasing trend in the percentage of CK7-and-CK20 cases, most pronounced around 2011–2014, possibly due to the availability of newer biomarkers; however, the observed decrease seemed to have reached a plateau in the most recent years.
← all excerpts
Revisiting the use of CK7 and CK20 immunohistochemical stains in pathological diagnoses.
1
—
—